Your session is about to expire
← Back to Search
Peer Coaching for Congenital Heart Disease (CHASM in ACHD Trial)
CHASM in ACHD Trial Summary
This trial will test whether peer coaching can help young adults with congenital heart disease.
CHASM in ACHD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCHASM in ACHD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CHASM in ACHD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a smartphone.You have difficulty with thinking and understanding.I am between 18 and 26 years old.I was born with a heart condition.
- Group 1: Education only
- Group 2: Peer Coaching
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are elderly individuals being sought for involvement in this trial?
"The trial is only open to individuals aged between 18 and 26. Separately, there are 95 studies for minors and 268 trials targeting seniors."
Are there any opportunities for recruitment into this research project?
"Clinicaltrials.gov verifies that this clinical trial, which was initially posted on October 8th 2020 is presently recruiting participants. The most recent update to the study's information occurred on October 26th 2021."
How many individuals have been accepted into this clinical investigation?
"Affirmative. The commencement date of this medical study is October 8th 2020, according to the clinicaltrials.gov repository, and it is presently recruiting 80 test subjects across one site."
Are there any qualifications that must be met to partake in this trial?
"To be eligible for this clinical investigation, potential participants must have a diagnosis of congenital heart disease and fall between the age brackets of 18 to 26. A total of 80 enrollees are being accepted into the trial."
What is the chief aim of this investigation?
"During this trial, assessors will track participants over the 3-month and 6-month intervals to evaluate the number of enrollees. Secondary parameters include gauging shifts in transition preparedness using TRAQ scores, changes in emotional health assessed with BSI metrics, and successful adult cardiology referrals which must be maintained for a decade post study."
Share this study with friends
Copy Link
Messenger